spacer
home > epc > autumn 2018 > clinical service
PUBLICATIONS
European Pharmaceutical Contractor

Clinical Service

With the NHS currently facing some of its greatest challenges in a 70-year history, clinical trials for new treatments and technologies could provide the solutions to seemingly insurmountable problems: endless surgery waiting lists, bed-blocking, and clinicians and nurses stretched to their limit. Do public-private partnerships between the NHS and medical technology developers hold the key?

Successful outcomes in device development and the development of clinical and health economic benefits rely heavily on the strong partnerships between clinicians and med-tech developers, with both parties committed to improving outcomes for patients. The clinicians that embrace innovation and that are forward-thinking must be championed. Collaborating with those willing to invest in and introduce evidence-based therapies to simplify treatments will help build a more robust health system that is moving forward, rather than stuck in its tracks under strain.

2018 marks the NHS’s 70th birthday, and, as the British institution celebrates 70 years of service, the general public rushed to express their gratitude; from cradle to grave, the NHS is hailed for its care for every citizen, no matter their condition, circumstance, or means.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Bernard Ross is the CEO at Sky Medical Technology, a UK-based medical devices company. Bernard and the company develop a range of products tailored to the needs of different medical application areas, selling both directly and through strategic partnerships or distributors in each major clinical area. Clinical areas of interest include reduction of oedema, prevention of venous thromboembolism, wound healing, and elite sport recovery.
spacer
Bernard Ross
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Zenith Technologies win Cork Company of the Year

We’re very proud to announce that last Friday we won the Cork Company of the Year Award in the corporate category.
More info >>

White Papers

Translating Cancer Genomics Into A Personalised Approach For Cancer Patients

PRA Health Sciences (PRA)

Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patient’s particular disease at a precise time point) is being performed every day at different levels in the clinical setting.
More info >>

 
Industry Events

14th Annual Biomarkers Congress

21-22 February 2019, Manchester Central Convention Complex, UK

Oxford Global is proud to present for the 14th year our flagship Biomarkers Congress, taking place 21 – 22 February 2019 in Manchester, UK. An updated programme ensures you will benefit from talks on the latest strategies and technologies impacting growth in the biomarker industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement